| Clinical study "common" name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year completed | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results A Retrospective, Comparative Study | N=30 | N/A | 43497 | Erden B, et al. Comparison of intravitreal aflibercept and ranibizumab for treatment of myopic choroidal neovascularization: one-year results a retrospective, comparative study. J Ophthalmol. 2019;2019:8639243. https://www.hindawi.com/journals/joph/2019/8639243/ | N/A |